A Randomized Trial Comparing Extended-Release Injectable Suspension and Oral Naltrexone, Both Combined With Behavioral Therapy, for the Treatment of Opioid Use Disorder-Reference-Cited by-同舟云学术

A Randomized Trial Comparing Extended-Release Injectable Suspension and Oral Naltrexone, Both Combined With Behavioral Therapy, for the Treatment of Opioid Use Disorder

Published:2019-02 Issue:2 Volume:176 Page:129-137
ISSN:0002-953X
Container-title:American Journal of Psychiatry
language:en
Short-container-title:AJP

Author:

Sullivan Maria A.¹,Bisaga Adam¹,Pavlicova Martina¹,Carpenter Kenneth M.¹,Choi C. Jean¹,Mishlen Kaitlyn¹,Levin Frances R.¹,Mariani John J.¹,Nunes Edward V.¹

Affiliation:

1. From the Division on Substance Use, Department of Psychiatry, Columbia University and New York State Psychiatric Institute, New York; the Mailman School of Public Health, Columbia University, New York; and Alkermes, Waltham, Mass.

Publisher

American Psychiatric Association Publishing

Subject

Psychiatry and Mental health

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medial prefrontal neuroplasticity during extended-release naltrexone treatment of opioid use disorder – a longitudinal structural magnetic resonance imaging study;Translational Psychiatry;2024-09-05

2. A pilot randomized controlled trial of medication adherence therapy: Psychosocial leverage using a significant other (MAT-PLUS) for individuals on extended-release naltrexone;Journal of Substance Use and Addiction Treatment;2024-08

3. Opioid Maintenance Therapy: A Review of Methadone, Buprenorphine, and Naltrexone Treatments for Opioid Use Disorder;Seminars in Neurology;2024-06-07

4. Informing evidence-based medicine for opioid use disorder using pharmacoeconomic studies;Expert Review of Pharmacoeconomics & Outcomes Research;2024-05-09

5. Rapid Initiation of Injection Naltrexone for Opioid Use Disorder;JAMA Network Open;2024-05-08